The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Raskob, G. E., van Es, N., Verhamme, P., Carrier, M., Di Nisio, M., Garcia, D., Grosso, M. A., Kakkar, A. K., Kovacs, M. J., Mercuri, M. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711948 · Cited by 1,633
Self-citationKey, N. S., Khorana, A. A., Kuderer, N. M., Bohlke, K., Lee, A. Y. Y., Arcelus, J. I., Wong, S. L., Balaban, E. P., Flowers, C. R., Francis, C. W., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01461 · Cited by 1,504
Self-citationYoung, A. M., Marshall, A., Thirlwall, J., Chapman, O., Lokare, A., Hill, C., Hale, D., Dunn, J. A., Lyman, G. H., Hutchinson, C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8034 · Cited by 1,348
Self-citationBARBAR, S., NOVENTA, F., ROSSETTO, V., FERRARI, A., BRANDOLIN, B., PERLATI, M., DE BON, E., TORMENE, D., PAGNAN, A., & PRANDONI, P. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04044.x · Cited by 1,240
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Agnelli, G., Becattini, C., Meyer, G., Muñoz, A., Huisman, M. V., Connors, J. M., Cohen, A., Bauersachs, R., Brenner, B., Torbicki, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915103 · Cited by 1,067
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012385 · Cited by 1,052
Deep vein thrombosis and pulmonary embolism
Di Nisio, M., van Es, N., & Büller, H. R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30514-1 · Cited by 994
Self-citationThe PREPIC Study Group (2005) · Circulation · doi:10.1161/circulationaha.104.512834 · Cited by 931
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Carrier, M., Abou-Nassar, K., Mallick, R., Tagalakis, V., Shivakumar, S., Schattner, A., Kuruvilla, P., Hill, D., Spadafora, S., Marquis, K., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814468 · Cited by 852
Venous thromboembolism in cancer patients: a population-based cohort study
Mulder, F. I., Horváth-Puhó, E., van Es, N., van Laarhoven, H. W. M., Pedersen, L., Moik, F., Ay, C., Büller, H. R., & Sørensen, H. T. (2021) · Blood · doi:10.1182/blood.2020007338 · Cited by 723
Self-citationRivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Khorana, A. A., Soff, G. A., Kakkar, A. K., Vadhan-Raj, S., Riess, H., Wun, T., Streiff, M. B., Garcia, D. A., Liebman, H. A., Belani, C. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814630 · Cited by 719
Agnelli, G., Bolis, G., Capussotti, L., Scarpa, R. M., Tonelli, F., Bonizzoni, E., Moia, M., Parazzini, F., Rossi, R., Sonaglia, F., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000193959.44677.48 · Cited by 690
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
McBane, R. D., Wysokinski, W. E., Le‐Rademacher, J. G., Zemla, T., Ashrani, A., Tafur, A., Perepu, U., Anderson, D., Gundabolu, K., Kuzma, C., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14662 · Cited by 591
Khorana, A. A., Noble, S., Lee, A. Y. Y., Soff, G., Meyer, G., O'Connell, C., & Carrier, M. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14219 · Cited by 442
RASMUSSEN, M. S., JORGENSEN, L. N., WILLE‐JØRGENSEN, P., NIELSEN, J. D., HORN, A., MOHN, A. C., SØMOD, L., & OLSEN, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02153.x · Cited by 371
duPre', S. A., & Hunter, K. W. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.06.007 · Cited by 309
Katholing, A., Rietbrock, S., Bamber, L., Martinez, C., & Cohen, A. T. (2017) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0686 · Cited by 294
Mechanisms and risk factors of thrombosis in cancer
Falanga, A., Russo, L., Milesi, V., & Vignoli, A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.08.003 · Cited by 269
Self-citationRiedl, J., Preusser, M., Nazari, P. M. S., Posch, F., Panzer, S., Marosi, C., Birner, P., Thaler, J., Brostjan, C., Lötsch, D., et al. (2017) · Blood · doi:10.1182/blood-2016-06-720714 · Cited by 231
Self-citationMerkow, R. P., Bilimoria, K. Y., McCarter, M. D., Cohen, M. E., Barnett, C. C., Raval, M. V., Caprini, J. A., Gordon, H. S., Ko, C. Y., & Bentrem, D. J. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31821b98da · Cited by 229
Geersing, G. J., Zuithoff, N. P. A., Kearon, C., Anderson, D. R., ten Cate-Hoek, A. J., Elf, J. L., Bates, S. M., Hoes, A. W., Kraaijenhagen, R. A., Oudega, R., et al. (2014) · BMJ · doi:10.1136/bmj.g1340 · Cited by 227
Bergqvist, D., Burmark, U. S., Flordal, P. A., Frisell, J., Hallböökr, T., Hedberg, M., Horn, A., Kelty, E., Kvitting, P., Lindhagen, A., et al. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800820421 · Cited by 218
KOVACS, M. J., KAHN, S. R., RODGER, M., ANDERSON, D. R., ANDREOU, R., MANGEL, J. E., MORROW, B., CLEMENT, A. M., & WELLS, P. S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02613.x · Cited by 200
Zonder, J. A., Crowley, J., Hussein, M. A., Bolejack, V., Moore, D. F., Whittenberger, B. F., Abidi, M. H., Durie, B. G. M., & Barlogie, B. (2010) · Blood · doi:10.1182/blood-2010-08-303487 · Cited by 194
CARRIER, M., LE GAL, G., TAY, J., WU, C., & LEE, A. Y. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04215.x · Cited by 193
Mulder, F. I., Bosch, F. T. M., Young, A. M., Marshall, A., McBane, R. D., Zemla, T. J., Carrier, M., Kamphuisen, P. W., Bossuyt, P. M. M., Büller, H. R., et al. (2020) · Blood · doi:10.1182/blood.2020005819 · Cited by 181
Self-citationSanfilippo, K. M., Luo, S., Wang, T., Fiala, M., Schoen, M., Wildes, T. M., Mikhael, J., Kuderer, N. M., Calverley, D. C., Keller, J., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25603 · Cited by 176
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer
Kahale, L. A., Hakoum, M. B., Tsolakian, I. G., Alturki, F., Matar, C. F., Terrenato, I., Sperati, F., Barba, M., Yosuico, V. E. D., Schünemann, H. J., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006650.pub5 · Cited by 170
Moss, J. G., Wu, O., Bodenham, A. R., Agarwal, R., Menne, T., Jones, B. L., Heggie, R., Hill, S., Dixon-Hughes, J., Soulis, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00766-2 · Cited by 169
Kakkos, S. K., Caprini, J. A., Geroulakos, G., Nicolaides, A. N., Stansby, G., Reddy, D. J., & Ntouvas, I. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005258.pub3 · Cited by 165
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism
Planquette, B., Bertoletti, L., Charles-Nelson, A., Laporte, S., Grange, C., Mahé, I., Pernod, G., Elias, A., Couturaud, F., Falvo, N., et al. (2022) · Chest · doi:10.1016/j.chest.2021.09.037 · Cited by 163
Li, A., Wu, Q. V., Luo, S., Warnick, G. S., Zakai, N. A., Libby, E. N., Gage, B. F., Garcia, D. A., Lyman, G. H., & Sanfilippo, K. M. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7273 · Cited by 151
Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
Carrier, M., Khorana, A. A., Moretto, P., Gal, G. L., Leaf, R. K., & Zwicker, J. I. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.09.015 · Cited by 149
Elice, F., Fink, L. M., Tricot, G. J. K., Barlogie, B., & Zangari, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06208.x · Cited by 135
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Jara‐Palomares, L., Solier-López, A., Elías-Hernández, T., Asensio-Cruz, M., Blasco-Esquivias, I., Marín-Barrera, L., de la Borbolla-Artacho, M. R., Praena‐Fernández, J. M., Romero, E. M., Navarro‐Herrero, S., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.07.004 · Cited by 135
Self-citationNapolitano, M., Saccullo, G., Malato, A., Sprini, D., Ageno, W., Imberti, D., Mascheroni, D., Bucherini, E., Gallucci, P., D’Alessio, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7433 · Cited by 113
Savage, K. J. J., Wells, P. S., Schulz, V., Goudie, D., Morrow, B., Cruickshank, M., & Kovacs, M. J. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614319 · Cited by 108
Davies, G. A., Lazo‐Langner, A., Gándara, E., Rodger, M. A., Tagalakis, V., Louzada, M., Corpuz, R., & Kovacs, M. J. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.04.003 · Cited by 106
Kreuziger, L. B., Jaffray, J., & Carrier, M. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.07.002 · Cited by 102
Bradbury, C. A., Craig, Z., Cook, G., Pawlyn, C., Cairns, D. A., Hockaday, A., Paterson, A., Jenner, M. W., Jones, J. R., Drayson, M. T., et al. (2020) · Blood · doi:10.1182/blood.2020005125 · Cited by 98
Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients
Falanga, A., Schieppati, F., & Russo, L. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-20315-3_2 · Cited by 91
Self-citationMultiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
Zamagni, E., Brioli, A., Tacchetti, P., Zannetti, B. A., Pantani, L., & Cavo, M. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273085 · Cited by 90
Marshall, A., Levine, M. N., Hill, C. S., Hale, D., Thirlwall, J., Wilkie, V., French, K., Kakkar, A. K., Lokare, A., Maraveyas, A., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14752 · Cited by 87
Self-citationAkl, E. A., Kahale, L. A., Sperati, F., Neumann, I., Labedi, N., Terrenato, I., Barba, M., Sempos, E. V., Muti, P. C., Cook, D., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009447.pub2 · Cited by 86
Anticoagulation for people with cancer and central venous catheters
Kahale, L. A., Tsolakian, I. G., Hakoum, M. B., Matar, C. F., Barba, M., Yosuico, V. E. D., Terrenato, I., Sperati, F., Schünemann, H. J., & Akl, E. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006468.pub6 · Cited by 85
Paludo, J., Mikhael, J. R., LaPlant, B. R., Halvorson, A. E., Kumar, S. K., Gertz, M. A., Hayman, S. R., Buadi, F. K., Dispenzieri, A. A., Lust, J. A., et al. (2017) · Blood · doi:10.1182/blood-2017-05-782961 · Cited by 80
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Rutjes, A. W., Porreca, E., Candeloro, M., Valeriani, E., & Nisio, M. D. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008500.pub5 · Cited by 79
Nisio, M. D., van Es, N., Carrier, M., Wang, T., Garcia, D. A., Segers, A., Weitz, J. I., Buller, H. R., & Raskob, G. E. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14561 · Cited by 71
Catheter-related thrombosis: lifeline or a pain in the neck?
Kamphuisen, P. W., & Lee, A. Y. Y. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.638.3798656 · Cited by 71
Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance
Palumbo, A., & Palladino, C. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612452291 · Cited by 70
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
Hakoum, M. B., Kahale, L. A., Tsolakian, I. G., Matar, C. F., Yosuico, V. E. D., Terrenato, I., Sperati, F., Barba, M., Schünemann, H. J., & Akl, E. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006649.pub7 · Cited by 65
Moik, F., Colling, M. E., Mahé, I., Jara‐Palomares, L., Pabinger, I., & Ay, C. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15599 · Cited by 63
Self-citationCaprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients
Sterbling, H. M., Rosen, A. K., Hachey, K. J., Vellanki, N., Hewes, P. D., Rao, S. R., Pinjić, E., Fernando, H. C., & Litle, V. R. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.10.013 · Cited by 62
Rodon, P., Hulin, C., Daley, L., Dauriac, C., Hacini, M., Decaux, O., Eisemann, J.-C., Fitoussi, O., Lioure, B., Voillat, L., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0140 · Cited by 61
Jara‐Palomares, L., Solier-López, A., Elías-Hernández, T., Asensio-Cruz, M. I., Blasco-Esquivias, I., Sánchez‐López, V., de la Borbolla, M. R., Arellano‐Orden, E., Suárez-Valdivia, L., Marín-Romero, S., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0269-5 · Cited by 56
Self-citationRivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Cohen, A. T., Spiro, T. E., & Spyropoulos, A. C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1303641 · Cited by 54
Zwicker, J. I., Rojan, A. A., Campigotto, F., Rehman, N., Funches, R., Connolly, G. C., Webster, J. A., Aggarwal, A., Mobarek, D. A., Faselis, C. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5336 · Cited by 50
Anticoagulation for perioperative thromboprophylaxis in people with cancer
Matar, C. F., Kahale, L. A., Hakoum, M. B., Tsolakian, I. G., Etxeandia‐Ikobaltzeta, I., Yosuico, V. E. D., Terrenato, I., Sperati, F., Barba, M., Schünemann, H. J., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009447.pub3 · Cited by 47
Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer
Guo, Q., Huang, B., Zhao, J., Ma, Y., Yuan, D., Yang, Y., & Du, X. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000002074 · Cited by 46
Carrier, M., Altman, A. D., Blais, N., Diamantouros, A., McLeod, D., Moodley, U., Nguyen, C. P., Young, S. W., & Schwenter, F. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.11.046 · Cited by 45
Schünemann, H. J., Ventresca, M., Crowther, M. A., Briel, M., Zhou, Q. X., Noble, S., Macbeth, F. R., Griffiths, G. O., Garcia, D. A., Lyman, G. H., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30293-3 · Cited by 40
Self-citationCaiano, L. M., Carrier, M., Marshall, A., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15435 · Cited by 36
Cini, M., Zamagni, E., Valdré, L., Palareti, G., Patriarca, F. F., Tacchetti, P., Legnani, C., Catalano, L., Masini, L., Tosi, P., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01434.x · Cited by 35
Rivaroxaban in the Treatment of PICC-associated Upper Extremity Venous Thrombosis
Fan, F., Zou, Y., Zhang, S., Zhang, Y., Lan, B., Song, Q., Pei, M., He, L., Wu, H., Du, Y., et al. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.07.041 · Cited by 35
Fotiou, D., Sergentanis, T. Ν., Papageorgiou, L., Stamatelopoulos, K., Gavriatopoulou, M., Kastritis, E., Ψαλτοπούλου, Θ., Salta, S., Dreden, P. V., Sangare, R., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0135-y · Cited by 35
Self-citationJiang, M., Li, C.-L., Pan, C., Cui, X., & Dietrich, C. F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14930 · Cited by 35
Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma
Huang, H., Li, H., & Li, D. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000296 · Cited by 31
Boddi, M., Villa, G., Chiostri, M., Antoniis, F. D., Fanti, I. D., Spinelli, A. M., Savino, A., Gensini, G. F., & Pelagatti, C. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12519 · Cited by 27
Baker, H. A., Brown, A. R., Mahnken, J. D., Shireman, T. I., Webb, C., & Lipe, B. C. (2018) · Cancer Medicine · doi:10.1002/cam4.1927 · Cited by 23
Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps
Leader, A., Cate, H. T., Spectre, G., Beckers, E. A. M., & Falanga, A. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.09.014 · Cited by 22
Self-citationAn update on prevention of venous thromboembolism in hospitalized acutely ill medical patients
Samama, M. M., & Kleber, F. X. (2006) · Thrombosis Journal · doi:10.1186/1477-9560-4-8 · Cited by 17
Brown, J. D., & Adams, V. R. (2016) · Healthcare · doi:10.3390/healthcare4010016 · Cited by 16
Updates on thrombotic events associated with multiple myeloma
Fotiou, D., Gavriatopoulou, M., Ntanasis‐Stathopoulos, I., Migkou, M., Dimopoulos, M. A., & Terpos, E. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1604214 · Cited by 16
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
Brown, J. D., Adams, V. R., & Moga, D. C. (2016) · Healthcare · doi:10.3390/healthcare4040093 · Cited by 7
Cited by
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Conroy, T., Pfeiffer, P., Vilgrain, V., Lamarca, A., Seufferlein, T., O’Reilly, E. M., Hackert, T., Golan, T., Prager, G., Haustermans, K., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.08.009 · Cited by 610
Mechanisms and management of thrombosis in cancer: Focus on gastrointestinal malignancies
Monegatti, S., Martinelli, N., Friso, S., Spronk, H. M. H., & Cate, H. T. (2025) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002203 · Cited by 10
Metadata
- Authors
- Falanga, A., Ay, C., Di Nisio, M., Gerotziafas, G., Jara-Palomares, L., Langer, F., Lecumberri, R., Mandala, M., Maraveyas, A., Pabinger, I., Sinn, M., Syrigos, K., Young, A., & Jordan, K.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 34
- Issue
- 5
- Pages
- 452-467
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4313907836
- Cited by
- 413
- References
- 77
- FWCI
- 91.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.